Clinical Management of Patients With Stable Ischemic Heart Disease

Subo Dey1, Andy Wang1, Matthew McMaster1

  • 1From the Departments of Medicine.

Insights

Stable ischemic heart disease management involves symptom control and risk factor optimization. Coronary computed tomography angiography is a first-line test, with invasive coronary angiography as the gold standard for diagnosis.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Interventional Cardiology

Background:

  • Stable ischemic heart disease requires careful management of symptoms and comorbidities.
  • Noninvasive imaging plays a crucial role in diagnosis based on pretest probability.
  • Optimizing comorbidities like hyperlipidemia, hypertension, and diabetes is essential.

Purpose of the Study:

  • To outline the diagnostic and management strategies for stable ischemic heart disease.
  • To emphasize the role of imaging modalities in evaluating coronary artery disease.
  • To discuss revascularization options for persistent symptoms.

Main Methods:

  • Utilizing pretest probability to guide noninvasive imaging, with coronary computed tomography angiography as the initial choice.
  • Employing invasive coronary angiography as the gold standard for definitive diagnosis.
  • Individualizing treatment based on clinical presentation, comorbidities, and disease severity.

Main Results:

  • Coronary computed tomography angiography serves as a primary noninvasive tool.
  • Invasive coronary angiography provides the gold standard for diagnosis.
  • Percutaneous coronary intervention and coronary artery bypass grafting are considered for persistent symptoms and specific patient subgroups.

Conclusions:

  • Management of stable ischemic heart disease necessitates a comprehensive approach including risk factor control and appropriate diagnostic testing.
  • Coronary computed tomography angiography is a valuable first-line diagnostic test.
  • Revascularization strategies should be tailored to individual patient profiles, including left main disease, left ventricular dysfunction, and multivessel disease.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
22
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
13
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K